Do not take reboxetine with
- any of the other medicines listed in the table Medicines that may increase risk of serotonin toxicity, unless under careful medical supervision
- illegal drugs
- moclobemide and wait at least 2 days after stopping moclobemide before taking reboxetine, because it may cause serotonin toxicity or a serious reaction with severe high blood pressure.
Tell your doctor if you are taking any of the following
Always tell your doctor about all other medicines you are taking, including over-the-counter and complementary or alternative medicines. You may need careful monitoring or a change in dose to avoid side effects if you are taking other medicines, including:
- medicines used to lower blood pressure
- antibiotics or medicines used to treat fungal infections (eg, ketoconazole [eg, Nizoral tablets])
- carbamazepine (Tegretol, Teril), for epilepsy
- diuretics (fluid tablets)
- ergot derivatives such as ergotamine (Cafergot), for migraine.
Reboxetine and alcohol
Reboxetine is not likely to increase the effects of alcohol, but it is generally not a good idea to drink alcohol if you are depressed or taking antidepressants.
Who can I ask about interactions?
Call the NPS Medicines Line on 1300 MEDICINE (1300 633 424) to get information about your prescription, over-the-counter and complementary medicines (herbal, ‘natural’, vitamins and minerals) from a pharmacist. Your call will be answered by healthdirect Australia.
Find out more about
- What reboxetine does and how effective it is
- Who reboxetine is for and who should be cautious
- Side effects of reboxetine
- Brands of reboxetine
If you are starting reboxetine, see 10 things you should know about antidepressants.
For more information
- Starting, switching and stopping antidepressants
- Managing side effects of antidepressants
- Psychological therapies
The consumer medicine information (CMI) for your brand of reboxetine is available from our website or a pharmacist. If you have any concerns about interactions, talk to your health professional. The CMI includes:
- how to take this medicine
- what to do if you forget to take it
- if you take too much (overdose)
- things you must and must not do while taking this medicine
- signs of severe reactions and what to do.
- Rossi S, ed. eAMH [online]. Adelaide: Australian Medicines Handbook, 2012. www.amh.net.au. (Accessed 9 February 2012).
- Psychotropic Expert Group. Therapeutic Guidelines: Psychotropic, Version 6. In: eTG complete [CD-ROM]. Melbourne: Therapeutic Guidelines Limited; 2008.
- Pfizer Australia Pty Ltd. Edronax product information. August 2011. (Accessed 22 March 2012).
- Edronax consumer medicine information. August 2011. www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-CMI-01669-3 (accessed 22 March 2012).